ENDPOINTS

Bill Meury brings new perspective to Incyte as Hoppenot retires; Ex-MorphoSys CEO leads revitalized Vor Bio

→ Hervé Hoppenot is handing the CEO post at Incyte to Bill Meury after 11 years leading the Delaware drugmaker. Endpoints News caught up with Hoppenot and Meury on their last and first days on ...

Jun 27, 2025 - 12:02
 0
Bill Meury brings new perspective to Incyte as Hoppenot retires; Ex-MorphoSys CEO leads revitalized Vor Bio
→ Hervé Hoppenot is handing the CEO post at Incyte to Bill Meury after 11 years leading the Delaware drugmaker. Endpoints News caught up with Hoppenot and Meury on their last and first days on ...
Read More

Tags:

Previous Article

SC river the 'most contaminated' from dangerous forever chemicals, study finds

Next Article

'Quantum AI' algorithms already outpace the fastest supercomputers, study says

Related Posts

Eli Lilly to buy gene editing biotech Verve Therapeutics for up to $1.3B

Eli Lilly to buy gene editing biotech Verve Therapeutic...

Jun 17, 2025  0

Another Bristol Myers exec goes to Acadia; David Southwell takes CEO job at ARCH-backed cancer biotech

Another Bristol Myers exec goes to Acadia; David Southw...

May 30, 2025  0

Exclusive: Insurance startup Devoted Health cuts 5% of workers in small layoff

Exclusive: Insurance startup Devoted Health cuts 5% of ...

May 28, 2025  0